Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

british_pharmacopeia

The British Pharmacopoeia 2018 now available

July 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Pharmacopoeia, biotech, drugs, healthcare, pharma, pharmaceutical

The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …
Feature
pills_in_pot

Over 3% of all drugs in Indian market not up to standard

July 24, 2017 Manufacturing and Production, Sales and Marketing India, biotech, drugs, pharma, pharmaceutical

The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that …
News
teva_copy

Teva to cut over 300 production jobs in Israel

July 24, 2017 Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical

Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …
News
laurie-glimcher-large

GSK unveil appointment coup for board of directors

July 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, GSK, biotech, drugs, immunooncology, pharma, pharmaceutical

GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
News
gsk_ulverston_plant_impression

GSK continues restructure by axing £350m Cumbria plant plans

July 21, 2017 Manufacturing and Production, Medical Communications GSK, GlaxoSmithKline, UK, biotech, drugs, pharma, pharmaceuticals

Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …
News
dr-nathan-brown

BenevolentAI installs new Head of Cheminformatics

July 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

BenevolentAI, a company that uses an artificial intelligence platform to improve drug discovery, has announced the appointment of Nathan Brown …
Appointment
smaller_size

Pushing the value of data

July 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Ray, NHS, NHS Digital, biotech, drugs, pharma, pharmaceutical

Daniel Ray, Head of NHS Digital discusses the importance of data usage in the healthcare system and the NHS Digital …
Feature
hoiland

Radius bolsters leadership with appointment of Novo Vet

July 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Radius, biotech, drugs, pharma, pharmaceutical

Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …
Appointment
joe_jimenez

Novartis CEO reasserts 2018 growth expectations, discusses Alcon and Sandoz future

July 18, 2017 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, biosimilars, biotech, healthcare, joe jimenez, leukaemia, pharma, pharmaceuticals

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …
News
breast_cancer_scan

FDA gives nod to drug that prevents breast cancer recurrence

July 18, 2017 Manufacturing and Production, Sales and Marketing Puma Biotech, biotech, drugs, pharma, pharmaceutical

Puma Biotech has pounced to secure FDA approval for its extended adjuvant treatment for early-stage, HER2-positive breast cancer. The drug, …
News

Merck to lay off 200 as part of 5-year reorganisation plan

July 18, 2017 Manufacturing and Production Merck, biotech, drugs, healthcare, pharma, pharmaceutical

German drug manufacturer Merck has announced its intention to streamline its manufacturing processes across Europe as part of a five-year …
News
valeant

Valeant takes huge loss on previous deal to pay down debts

July 18, 2017 Manufacturing and Production, Sales and Marketing Obagi Medical Products, Valeant, biotech, drugs, pharma, pharmaceutical

It is an odd time for Valeant, where selling a part of its business for half of what it paid, …
News
social-media-550766_640

Pharmafocus wants to hear from you!

July 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …
News
wood-1

GSK completes further high-profile staff acquisition

July 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …
Appointment
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026